Houston Methodist Model Demonstrates Reversal from Heart Failure State, Creating the Potential for Innovative Treatment Avenues

A preclinical model developed at Houston Methodist demonstrates genotypic and phenotypic reversal from heart failure and indicates possibility of new pathophysiological insights and therapeutic interventions.

Jumpstarting Dysfunctional Regulatory T cells into Action Could Help Treat Parkinson’s Disease

Houston Methodist researchers show that dysfunctional regulatory T cells are a hallmark of neuroinflammation in Parkinson’s disease. However, an ex vivo activation and expansion could restore the immunosuppression of these cells and provide a viable treatment strategy to combat chronic inflammation.